scholarly journals Proteomic research and diagnosis in bladder cancer: state of the art review

2021 ◽  
Vol 47 (3) ◽  
pp. 503-514
Author(s):  
Jorge Luis Wilson Jr. ◽  
Mariana Pereira Antoniassi ◽  
Paula Intasqui Lopes ◽  
Hatylas Azevedo
Author(s):  
H.Barton Grossman ◽  
Colin P.N Dinney

Author(s):  
Felice Crocetto ◽  
Biagio Barone ◽  
Matteo Ferro ◽  
Gian Maria Busetto ◽  
Evelina La Civita ◽  
...  

2007 ◽  
Vol 36 (2) ◽  
pp. 83-96 ◽  
Author(s):  
Bindu N. Setty ◽  
Nagaraj-Setty Holalkere ◽  
Dushyant V. Sahani ◽  
Raul N. Uppot ◽  
Mukesh Harisinghani ◽  
...  

Open Biology ◽  
2018 ◽  
Vol 8 (6) ◽  
pp. 180037 ◽  
Author(s):  
Jitske van den Bulk ◽  
Els ME Verdegaal ◽  
Noel FCC de Miranda

Cancer immunotherapy has experienced remarkable advances in recent years. Striking clinical responses have been achieved for several types of solid cancers (e.g. melanoma, non-small cell lung cancer, bladder cancer and mismatch repair-deficient cancers) after treatment of patients with T-cell checkpoint blockade therapies. These have been shown to be particularly effective in the treatment of cancers with high mutation burden, which places tumour-mutated antigens (neo-antigens) centre stage as targets of tumour immunity and cancer immunotherapy. With current technologies, neo-antigens can be identified in a short period of time, which may support the development of complementary, personalized approaches that increase the number of tumours amenable to immunotherapeutic intervention. In addition to reviewing the state of the art in cancer immunotherapy, we discuss potential avenues that can bring the immunotherapy revolution to a broader patient group including cancers with low mutation burden.


Author(s):  
T. A. Welton

Various authors have emphasized the spatial information resident in an electron micrograph taken with adequately coherent radiation. In view of the completion of at least one such instrument, this opportunity is taken to summarize the state of the art of processing such micrographs. We use the usual symbols for the aberration coefficients, and supplement these with £ and 6 for the transverse coherence length and the fractional energy spread respectively. He also assume a weak, biologically interesting sample, with principal interest lying in the molecular skeleton remaining after obvious hydrogen loss and other radiation damage has occurred.


Author(s):  
Carl E. Henderson

Over the past few years it has become apparent in our multi-user facility that the computer system and software supplied in 1985 with our CAMECA CAMEBAX-MICRO electron microprobe analyzer has the greatest potential for improvement and updating of any component of the instrument. While the standard CAMECA software running on a DEC PDP-11/23+ computer under the RSX-11M operating system can perform almost any task required of the instrument, the commands are not always intuitive and can be difficult to remember for the casual user (of which our laboratory has many). Given the widespread and growing use of other microcomputers (such as PC’s and Macintoshes) by users of the microprobe, the PDP has become the “oddball” and has also fallen behind the state-of-the-art in terms of processing speed and disk storage capabilities. Upgrade paths within products available from DEC are considered to be too expensive for the benefits received. After using a Macintosh for other tasks in the laboratory, such as instrument use and billing records, word processing, and graphics display, its unique and “friendly” user interface suggested an easier-to-use system for computer control of the electron microprobe automation. Specifically a Macintosh IIx was chosen for its capacity for third-party add-on cards used in instrument control.


Sign in / Sign up

Export Citation Format

Share Document